[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100534080":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":35,"locations":41,"responsibleParty":58,"collaborators":62,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":68,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":34,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":44,"whyStopped":34,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Centre Hospitalier Esquirol","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Personalised psychomotor therapy group","EXPERIMENTAL","1 psychomotor therapy session of 45 minutes per week for 12 weeks + Duke Health Scale.",[13],"Behavioral: Personalised psychomotor therapy",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual treatment group","ACTIVE_COMPARATOR","Standard treatment for depression administered by a doctor + a weekly telephone interview for 12 weeks to administer the Duke Health Scale.",[19],"Other: Usual treatment",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","Personalised psychomotor therapy","The content of the sessions will be personalised and determined solely by a qualified psychomotor therapist in charge of the patient, based on each participant's individual psychomotor profile, as determined from the initial assessment.\n\nThe 12 sessions will take place with the same PT in a dedicated room at the centre where the patient is being treated. The sessions will consist of a range of playful static and dynamic body exercises, including exercises for emotional and tonic regulation, tonic-postural adaptation, and perceptual-motor adaptation.\n\nNot all participants in the GP group will have the same progression, nature or frequency of exercises over the 12 sessions.\n\nThe study only allows for individual treatment. Other therapeutic approaches such as balneotherapy sessions, animal mediation, adapted physical activity programmes or targeted relaxation programmes are not permitted.\n\nDuring each session, the participant will be required to complete the Duke health profile.",[9],[27],"GP",{"type":6,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"Usual treatment","Participants in the GC group will continue to receive their usual depression treatment without any changes to their prescribed therapies. Their participation in the study will involve weekly monitoring of their quality of life using the Duke scale. A nurse or psychomotor therapist will conduct this monitoring during a weekly fifteen-minute telephone interview. The follow-up will begin one week after the inclusion visit and will last for 12 weeks. Telephone appointments will be scheduled jointly with the participant based on their availability.",[15],[33],"GC",null,[36],{"name":37,"role":38,"phone":39,"phoneExt":34,"email":40},"Aude PAQUET, Dr","CONTACT","+33555431127","aude.paquet@ch-esquirol-limoges.fr",[42],{"facility":43,"status":44,"city":45,"state":34,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"CH Esquirol","RECRUITING","Limoges","87000","France","FR",{"type":50,"coordinates":51},"Point",[52,53],1.24759,45.83362,{"lat":53,"lon":52},[56],{"name":57,"role":38,"phone":39,"phoneExt":34,"email":40},"Aude PAQUET",{"type":59,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":34,"oldOrganization":34},"PRINCIPAL_INVESTIGATOR","Aude Paquet","Psychomotor Therapist, Psychology PhD",[63],{"name":64,"class":65},"Direction Générale de l'Offre de Soins","OTHER_GOV","100534080","impact-of-psychomotor-therapy-on-the-quality-of-life-in-depression-100534080",false,"NCT06234176","Impact of Psychomotor Therapy on the Quality of Life in Depression","Influence of Psychomotor Therapy on Quality of Life in Patients With a Major Depressive Disorder: a Randomized Controlled Trial","PsyMot-Dep","Inclusion Criteria:\n\n* Diagnosis of depressive episode according to DSM-5 criteria.\n* HDRS \\> 16\n* Hospitalized or followed-up in one of the participating centers.\n* Affiliated or beneficiary of a social security scheme.\n* Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research).\n\nExclusion Criteria:\n\n* Psychiatric comorbidity (non-tobacco addiction, eating disorders, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders)\n* Sensory impairment or proven neurological pathology\n* History of neurological brain damage (including stroke, tumor, trauma resulting in loss of consciousness lasting more than 10 minutes)\n* Limited functional ability (difficulty in moving about, performing manual tasks or moving about)\n* Inability to understand questionnaires and study information\n* Inability to travel to the inclusion center (personal vehicle, public transport)\n* Pregnant or breast-feeding women, on declaration\n* Forced hospitalization, subjects under guardianship or trusteeship, lack of social protection","ALL","20 Years","60 Years",{"count":78,"type":79},128,"ESTIMATED","INTERVENTIONAL",[82],"NA","The effectiveness of psychomotor therapy in improving clinical outcomes or quality of life for individuals with depression is unclear.\n\nThe investigators will assess how the participants' quality of life and psychomotor profile change over time.\n\nThe study aims to compare the quality of life at 3 months between patients who received 3 months of personalised psychomotor therapy in addition to standard treatment and those who received standard treatment alone.\n\nThe study lasted for 6 months, and the investigators expects a total of 128 people to participate in this research across several hospital establishments. This study evaluates the effectiveness of two types of treatment, divided into two randomly selected groups.\n\nTo participate, individuals must have a medical diagnosis of major depressive disorder (MDD) and be between the ages of 20 and 60.\n\nThey must have depressive symptoms with an HDRS score greater than 16 and provide informed consent. They must be treated or hospitalised at the Centre Hospitalier Esquirol or the Centre Hospitalier Henri Laborit (France).\n\nAfter providing consent, they will undergo an initial clinical interview that evaluates anxiety, self-esteem, pleasure, and quality of life. The therapist assessed the participant's muscle tone, gross motor skills, praxis, manual dexterity, rhythm, processing of sensory information, and body image.\n\nFollowing the assessment, the participant was randomly assigned to either the experimental or control group.\n\nThe experimental group received the usual treatment for depression and underwent psychomotor therapy once a week for 12 weeks.\n\nThe control group received the standard treatment for depression and underwent weekly telephone interviews.\n\nAn assessment is scheduled at 1 month to evaluate the participant's health status, including any changes to treatment and assessment of anxiety and depressive symptoms.\n\nAnother interim check-up is scheduled at 3 months to assess the patient's health status. The interview will also assess any changes to treatment, anxiety and depressive symptoms, quality of life, and psychomotor function.\n\nA final visit will be scheduled at 6 months for an assessment of the participant's health. The interview will also assess any changes to treatment, anxiety and depressive symptoms, quality of life, and psychomotor function.",[85],"Major Depressive Disorder",[87,88,89,90,91],"psychomotor therapy","quality of life","major depressive disorder","psychomotor profile","sensory processing","2025-02-17",{"date":94,"type":95},"2025-02-19","ACTUAL",{"date":97,"type":95},"2024-04-01",{"date":99,"type":79},"2026-08",{"name":5,"class":6},1]